ADMA Biologics (NASDAQ: ADMA) CFO details stock and option holdings

Rhea-AI Filing Summary

ADMA Biologics CFO and Treasurer Terry Kohler filed an initial ownership report showing his equity stake in the company. He reported 91,166 stock options and 58,019 shares of common stock held directly. Footnotes explain these reflect previously granted stock options and restricted stock units that vest over four years.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kohler Terry

(Last) (First) (Middle)

C/O ADMA BIOLOGICS, INC.

5800 PARK OF COMMERCE BLVD. NW

(Street)

BOCA RATON FL 33487

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/26/2026

3. Issuer Name and Ticker or Trading Symbol
ADMA BIOLOGICS, INC. [ ADMA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO and Treasurer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	58,019(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	12/08/2035	Common Stock	91,166	$19.39	D

Explanation of Responses:

1. On December 8, 2025 (the "Grant Date"), ADMA Biologics, Inc. granted the Reporting Person 58,019 restricted stock units ("RSUs"), which vest 25% on the one-year anniversary of the Grant Date and each annual anniversary of the Grant Date, over four years, subject to the Reporting Person's continued service as of the applicable vesting date, and which RSUs will be settled into common stock upon vesting.

2. These stock options were granted to the Reporting Person on the Grant Date, and will vest over four years with 25% vesting on the Grant Date and the remaining 75% vesting monthly in equal installments over the next three years subject to the Reporting Person's continued service as of the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Terry Kohler, by Michael A. Goldstein as Attorney-in-fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ADMA (ADMA) CFO Terry Kohler report on his Form 3?

Terry Kohler reported his initial beneficial ownership in ADMA Biologics, including stock options and common stock. This Form 3 filing discloses equity awards previously granted to him as an executive and establishes his baseline holdings as a reporting insider.

How many stock options does ADMA CFO Terry Kohler hold?

Terry Kohler reported holding 91,166 stock options following the reported transactions. These options were granted earlier and vest over four years, with 25% vesting on the grant date and the remaining 75% vesting monthly over the next three years.

How many ADMA common shares does Terry Kohler beneficially own?

He reported beneficial ownership of 58,019 shares of common stock. According to the footnotes, these relate to restricted stock units granted on December 8, 2025 that convert into common stock upon vesting, subject to his continued service with the company.

What are the vesting terms of Terry Kohler’s ADMA RSUs?

The filing states he received 58,019 RSUs on December 8, 2025. These vest 25% on the one-year anniversary of the grant date and 25% on each subsequent annual anniversary over four years, assuming he continues serving the company on each vesting date.

How do Terry Kohler’s ADMA stock options vest over time?

The stock options vest over four years. 25% vested on the grant date, and the remaining 75% vest monthly in equal installments over the next three years, conditioned on his continued service on each applicable vesting date, according to the filing footnote.

Does this ADMA Form 3 show any insider buying or selling activity?

No buy or sell transactions are identified in this Form 3. The transactions are categorized as holdings, reflecting previously granted stock options and restricted stock units, and establishing Terry Kohler’s initial ownership position as an officer of ADMA Biologics.